SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-220342
Filing Date
2020-08-14
Accepted
2020-08-14 16:06:31
Documents
7
Effectiveness Date
2020-08-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d225004ddefa14a.htm DEFA14A 34606
2 GRAPHIC g225004g05e15.jpg GRAPHIC 23408
3 GRAPHIC g225004g16q56.jpg GRAPHIC 13701
4 GRAPHIC g225004g28i57.jpg GRAPHIC 79527
5 GRAPHIC g225004g62d05.jpg GRAPHIC 24728
6 GRAPHIC g225004g76c99.jpg GRAPHIC 32714
7 GRAPHIC g225004g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-20-220342.txt   294016
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38811 | Film No.: 201105015
SIC: 2836 Biological Products, (No Diagnostic Substances)